reporting of outcomes data for CABG and for percutaneous coronary intervention (PCI) has been adopted by other states, and it has become a mainstay of performance assessment in health care. Supporters of public reporting have advocated that it promotes accountability and it fosters a drive toward quality improvement efforts. In addition, by offering information to patients on best practices and best outcomes, it provides the opportunity for informed decisions regarding where to go for health care. Unfortunately, several studies have raised concerns that physicians' perception of limitations of risk adjustment to appropriately account for patients' risk and the fear of public reporting might lead to denial of care to high-risk patients (2) (3) (4) (5) and, in some cases, to outmigration of patients to states without public reporting (6) . Other studies have shown that referral patterns and consumer choices are not generally affected by available statistics (5,7). In addition, random variation can have a significant influence on hospital rankings, and it should be taken into account when interpreting data. Finally, the knowledge of variables included in risk-adjustment models can lead to attempts toward gaming the system (i.e., knowing that a specific variable is associated with an increased risk of mortality might lead to dishonestly over-coding for that particular variable). From a patient care perspective, the issue of denying care to the patients who might need it most remains the most compelling concern. Thus, the debate surrounding public reporting has continued incessantly over the past 2 decades. Whether the use of the combined interventions described earlier will result in the "intended" con- Harm or Benefit?
